Physician

Ali Valimahomed, M.D.

According to 2025 Medicare claims, Ali Valimahomed, M.D. (NPI: 1760807184) practices physical medicine and rehabilitation in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is ADVANCED ORTHOPEDIC AND SPORTS MEDICINE INSTITUTE PC (NPI: 1518033893; TIN: 222144948) and primary practice location at 07728-7904. Valimahomed is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Valimahomed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 520 traditional Medicare patients, billed 4,859 HCPCS/CPT codes, and received $388,822 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,666 prescription claims across 343 beneficiaries totaling $35,989 in drug costs, led by Movantik (Naloxegol Oxalate). DME data shows 147 claims. Open Payments data shows 262 records totaling $485,243. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments moved sharply higher in recent years, from $3,288 to $19,591.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	230	1,105	$95,942
2019	595	6,552	$405,999
2020	540	5,365	$413,817
2021	573	15,217	$459,008
2022	513	10,236	$389,733
2023	456	5,063	$433,361
2024	520	4,859	$388,822

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	20	53	$3,292
2016	N/R	34	$2,244
2017	52	114	$8,961
2018	167	390	$16,986
2019	373	1,663	$69,049
2020	366	2,041	$84,149
2021	362	1,860	$53,626
2022	367	1,865	$52,164
2023	346	1,619	$36,645
2024	343	1,666	$35,989

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	14	14	$1,173
2020	N/R	26	$318
2021	N/R	29	$1,307
2022	N/R	16	$907
2023	34	116	$25,175
2024	40	147	$19,591

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	165	165	$132
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	70	76	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	293	731	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	209	378	$72
72110	X-ray of lower and sacral spine, minimum of 4 views	126	132	$42

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Movantik	Naloxegol Oxalate	11	330	$4,401
Gabapentin	Gabapentin	428	16,070	$4,151
Lidocaine	Lidocaine	31	1,300	$3,727
Buprenorphine	Buprenorphine	35	980	$3,052
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	1,890	$1,669

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	29	136	$10,503
A6010	Collagen based wound filler, dry form, sterile, per gram of collagen	N	11	11	$9,088

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	256	$102,792	Nalu Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$382,452	Nalu Medical, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Valimahomed, M.D.?

Tedicare shows public-source Medicare data for Ali Valimahomed, M.D. (NPI 1760807184), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Valimahomed, M.D. have ACO affiliation data?

Ali Valimahomed, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Ali Valimahomed, M.D.?

Ali Valimahomed, M.D. is linked to ADVANCED ORTHOPEDIC AND SPORTS MEDICINE INSTITUTE PC (billing NPI 1518033893) in the available physician profile data.

Does Ali Valimahomed, M.D. have Open Payments data?

Ali Valimahomed, M.D. has 262 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.